Drugs & Targets Copiktra receives Positive CHMP Opinion for relapsed and refractory CLL and refractory FL April 02, 2021Vol.47 No.13
Drugs & Targets Keytruda receives FDA approval for esophageal or GEJ carcinoma March 26, 2021Vol.47 No.12
Drugs & Targets Evotec, Takeda collaborate on strategic RNA targeting drug discovery and development March 26, 2021Vol.47 No.12
Drugs & Targets CYNK-001 receives Fast Track designation from FDA for recurrent glioblastoma multiforme March 19, 2021Vol.47 No.11
Drugs & Targets Geneseeq, Illumina to develop and commercialize comprehensive cancer in-vitro diagnostic NGS kit in China March 19, 2021Vol.47 No.11
Drugs & Targets CD&R, Merck GHI, and McKesson Ventures invest oncology data and informatics company M2Gen March 19, 2021Vol.47 No.11
Drugs & Targets FDA approves Fotivda for relapsed or refractory advanced renal cell carcinoma March 12, 2021Vol.47 No.10
